Glucagon vs Anticholinergics in the Treatment of Acute Pancreatitis
- 1 April 1978
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 138 (4) , 535-538
- https://doi.org/10.1001/archinte.1978.03630280017011
Abstract
Sixty-two cases of acute pancreatitis, evaluated for severity according to uniform standards, were treated identically except that patients in one group received glucagon hydrochloride (group A) and those in the other oxyphenonium bromomethylate (group B). Each of the two homologous series comprised 31 patients, and mortality was the same for both groups (3/31, 10%). Statistical comparison of both series showed no significant differences in frequency of expected complications nor in fall of serum amylase levels. During treatment, serum calcium levels were significantly reduced in group A (P <.005), and the duration of the abdominal pain was shortened (P <.05). The volume of gastric aspirate was smaller in group B (P <.005), and vesical catheterization proved necessary more frequently (P <.005). Thus, similar results are obtained when glucagon or anticholinergics are employed in the treatment of acute pancreatitis, although secondary effects differ. (Arch Intern Med 138:535-538, 1978)This publication has 3 references indexed in Scilit:
- Patterns of incidence in acute pancreatitis.BMJ, 1975
- GLUCAGON IN TREATMENT OF ACUTE PANCREATITISThe Lancet, 1974
- Glucagon therapy in acute pancreatitisBritish Journal of Surgery, 1973